Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study (CGACDM - Older Adults in China)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorHenan Provincial People's Hospital

About this trial

With the continuous development of China's economy and the improvement of medical standards, the life expectancy of the Chinese population has significantly increased. Against the backdrop of accelerating aging in China, the incidence of age-related chronic non-communicable diseases (NCDs), such as cardiovascular and cerebrovascular diseases and chronic respiratory diseases, has risen remarkably. These diseases are characterized by multiple comorbidities, high disability rates, and high mortality rates, severely compromising the quality of life of older adults, exacerbating family burdens, and straining healthcare systems. This constitutes one of the major challenges faced by aging societies. Therefore, early detection and intervention of chronic diseases in older adults are critical measures to address population aging.

Comprehensive geriatric assessment (CGA), a core specialty of geriatric medicine, serves as a fundamental framework for the clinical identification of geriatric syndromes and multidisciplinary management. It is emerging as a key pathway to promote "healthy aging." Guided by this premise, this study aims to explore the application value of CGA in managing chronic diseases among older adults, with the goal of achieving full-cycle management for early detection, diagnosis, and treatment of chronic conditions in China's elderly population.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

1. Aged 60 years or older 2. Diagnosed with chronic diseases in the circulatory, respiratory, digestive, nervous, or endocrine systems, consistent with corresponding disease diagnostic criteria; 3. Availability of complete medical records; 4. Clear consciousness and ability to independently answer questions; 5. Signed informed consent form.

Disqualifiers

1. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances).

Trial population

The study population consisted of patients with chronic diseases in the elderly who underwent comprehensive geriatric assessment and management. Chronic diseases in the elderly included but were not limited to chronic heart failure, chronic obstructive pulmonary disease, cognitive dysfunction, and so on.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • comprehensive geriatric assessment

    Diagnostic test

    The comprehensive geriatric assessment (CGA) is a multi dimensional diagnostic process used to determine the medi cal, psychological, and functional capabilities of a frail elderly person to develop a coordinated and integrated plan for treat ment and long-term follow-up.

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Elderly patients with chronic diseases1 intervention
Group B: Healthy elderly population1 intervention

Trial outcomes

Primary outcomes

1

Major adverse events (MAE)

Major adverse events (MAE) in overall population, defined as composite of all-cause death, Heart Failure hospitalization, recurrent myocardial infarction, stroke, etc.

Time frame
These data is collected during follow-up visit at 3/6/12/24/36 months after discharge

Secondary outcomes

Other outcomes

1

Age for each participant

Time frame
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
2

Gender for each participant

Time frame
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
3

Height for each participant

Time frame
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
4

Weight for each participant

Time frame
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Henan Provincial People's Hospital

Lead sponsor

Geriatrics Research Institute of Henan Provincial People's Hospital

Collaborator

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Collaborator

This trial is not recruiting at the moment. You can still explore other options: